Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation

Pertussis is still observed in many countries despite of high vaccine coverage. Acellular pertussis (aP) vaccination is widely implemented in many countries as primary series in infants and as boosters in school-entry/adolescents/adults (including pregnant women in some). One novel strategy to impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Auderset, Floriane, Ballester, Marie, Mastelic-Gavillet, Beatris, Fontannaz, Paola, Chabaud-Riou, Martine, Reveneau, Nathalie, Garinot, Marie, Mistretta, Noëlle, Liu, Yuanqing, Lambert, Paul-Henri, Ochs, Martina, Siegrist, Claire-Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618515/
https://www.ncbi.nlm.nih.gov/pubmed/31333656
http://dx.doi.org/10.3389/fimmu.2019.01520

Ejemplares similares

Ejemplares similares